Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
29m agoe.l.f. Cosmetics Fuels Katherine Legge's Return to the Indianapolis 500 with eyes.lips.fuel. Takeover
1h agoInvestor Update Webcast March 2026 Quarter
1h agoCiti Singapore receives dual award recognition from FinanceAsia and Forbes
3h agoEyebright Medical Releases Its 2025 Annual Report and Sustainability Report
3h agoThe Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership

Eupraxia Pharmaceuticals Inc

About

Eupraxia Pharmaceuticals Inc (TO:EPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
Apr 21 2026
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis 
Apr 13 2026
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
Mar 17 2026
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
Mar 13 2026
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

Financials

Revenue
CA$0
Market Cap
CA$611.96 M
EPS
-1.43

Community Chat

Ask AI

6ix6ix